Wider patient population beckons for Edwards' Sapien with panel thumbs up
This article was originally published in Clinica
Executive Summary
A US FDA advisory panel has voted for the approval of Edwards Lifesciences' Sapien transcatheter heart valve in a broader population to include high-risk patients able to undergo open-heart surgery.